Unbalanced risk-benefit analysis of ADHD drugs
- PMID: 30401440
- DOI: 10.1016/S2215-0366(18)30334-1
Unbalanced risk-benefit analysis of ADHD drugs
Comment in
-
Unbalanced risk-benefit analysis of ADHD drugs - Authors' reply.Lancet Psychiatry. 2018 Nov;5(11):871-873. doi: 10.1016/S2215-0366(18)30396-1. Epub 2018 Oct 26. Lancet Psychiatry. 2018. PMID: 30401441 No abstract available.
Comment on
-
Meta-Analyses in Child and Adolescent Psychiatry: Getting Closer to Clinical Practice.J Am Acad Child Adolesc Psychiatry. 2018 Apr;57(4):229-230. doi: 10.1016/j.jaac.2018.01.019. J Am Acad Child Adolesc Psychiatry. 2018. PMID: 29588046
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical